GRPR and prostate carcinoma: This study successfully introduced multiple bis-deoxygalactosyl-carborane building blocks to a GRPR-selective ligand, resulting in conjugates carrying up to 80 boron atoms per molecule, which demonstrated successful internalisation into PC3 prostate cancer cells that express the GRPR.